Carvedilol

CAS No. 72956-09-3

Carvedilol ( BM 14190 )

Catalog No. M15790 CAS No. 72956-09-3

Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 37 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carvedilol
  • Note
    Research use only, not for human use.
  • Brief Description
    Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.
  • Description
    Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.
  • Synonyms
    BM 14190
  • Pathway
    Endocrinology/Hormones
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor; HIF; E-selectin; NADPH; Vcam; Potassium Channel; VEGFR
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    72956-09-3
  • Formula Weight
    406.47
  • Molecular Formula
    C24H26N2O4
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 4 mg/mL (9.84 mM); DMSO: 81 mg/mL (199.27 mM)
  • SMILES
    COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
  • Chemical Name
    1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Koshimizu TA, et al. Cardiovasc Res. 2004 Sep 1; 63(4):662-72.
molnova catalog
related products
  • Tulobuterol hydrochl...

    Tulobuterol (INN) is a long-acting beta2-adrenergic receptor agonist.

  • Clorprenaline hydroc...

    Clorprenaline hydrochloride is a β2-receptor agonist, it has a significant expansion of the bronchial effect.

  • Yohimbine hydrochlor...

    Yohimbine hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.